ID   SGCA_HUMAN              Reviewed;         387 AA.
AC   Q16586; A6NEB8; A8K3K7; Q13710; Q13712;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 211.
DE   RecName: Full=Alpha-sarcoglycan;
DE            Short=Alpha-SG;
DE   AltName: Full=50 kDa dystrophin-associated glycoprotein;
DE            Short=50DAG;
DE   AltName: Full=Adhalin;
DE   AltName: Full=Dystroglycan-2;
DE   Flags: Precursor;
GN   Name=SGCA; Synonyms=ADL, DAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LGMDR3 HIS-98 AND ALA-175.
RC   TISSUE=Skeletal muscle;
RX   PubMed=8069911; DOI=10.1016/0092-8674(94)90527-4;
RA   Roberds S.L., Leturcq F., Allamand V., Piccolo F., Jeanpierre M.,
RA   Anderson R.D., Lim L.E., Lee J.C., Tome F.M.S., Romero N.B., Fardeau M.,
RA   Beckmann J.S., Kaplan J.-C., Campbell K.P.;
RT   "Missense mutations in the adhalin gene linked to autosomal recessive
RT   muscular dystrophy.";
RL   Cell 78:625-633(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Heart ventricle;
RX   PubMed=7937874; DOI=10.1073/pnas.91.21.9690;
RA   McNally E., Yoshida M., Mizuno Y., Ozawa E., Kunkel L.M.;
RT   "Human adhalin is alternatively spliced and the gene is on chromosome
RT   17q21.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9690-9694(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-214, AND VARIANT LGMDR3 CYS-77.
RX   PubMed=8528203; DOI=10.1093/hmg/4.7.1163;
RA   Bueno M.R.P., Moreira E.S., Vainzof M., Chamberlain J., Marie S.K.,
RA   Pereira L., Akiyama J., Roberds S.L., Campbell K.P., Zatz M.;
RT   "A common missense mutation in the adhalin gene in three unrelated
RT   Brazilian families with a relatively mild form of autosomal recessive limb-
RT   girdle muscular dystrophy.";
RL   Hum. Mol. Genet. 4:1163-1167(1995).
RN   [8]
RP   VARIANTS LGMDR3 CYS-77; PRO-GLY-ALA-GLN-PRO-136 INS; GLY-137 AND
RP   PRO-GLY-ALA-GLN-PRO-136 INS.
RX   PubMed=7657792; DOI=10.1172/jci118152;
RA   Kawai H., Akaike M., Endo T., Adachi K., Inui T., Mitsui T., Kashiwagi S.,
RA   Fujiwara T., Okuno S., Shin S., Miyoshi K., Campbell K.P., Yamada H.,
RA   Shimizu T., Matsumura K., Saito S.;
RT   "Adhalin gene mutations in patients with autosomal recessive childhood
RT   onset muscular dystrophy with adhalin deficiency.";
RL   J. Clin. Invest. 96:1202-1207(1995).
RN   [9]
RP   VARIANTS LGMDR3 HIS-34; HIS-62; GLU-68; CYS-77; HIS-98; ALA-242 AND
RP   MET-247.
RX   PubMed=7663524; DOI=10.1038/ng0695-243;
RA   Piccolo F., Roberds S.L., Jeanpierre M., Leturcq F., Azibi K., Beldjord C.,
RA   Carrie A., Recan D., Chaouch M., Reghis A., El Kerch F., Sefiani A.,
RA   Voit T., Merlini L., Collin H., Eymard B., Beckmann J.S., Romero N.B.,
RA   Tome F.M.S., Fardeau M., Campbell K.P., Kaplan J.-C.;
RT   "Primary adhalinopathy: a common cause of autosomal recessive muscular
RT   dystrophy of variable severity.";
RL   Nat. Genet. 10:243-245(1995).
RN   [10]
RP   ERRATUM OF PUBMED:7663524.
RA   Piccolo F., Roberds S.L., Jeanpierre M., Leturcq F., Azibi K., Beldjord C.,
RA   Carrie A., Recan D., Chaouch M., Reghis A., El Kerch F., Sefiani A.,
RA   Voit T., Merlini L., Collin H., Eymard B., Beckmann J.S., Romero N.B.,
RA   Tome F.M.S., Fardeau M., Campbell K.P., Kaplan J.-C.;
RL   Nat. Genet. 11:104-104(1995).
RN   [11]
RP   VARIANTS LGMDR3 LEU-30; CYS-34; CYS-77; ARG-91; THR-124; LYS-137; PRO-173
RP   AND CYS-284.
RX   PubMed=9192266; DOI=10.1136/jmg.34.6.470;
RA   Carrie A., Piccolo F., Leturcq F., de Toma C., Azibi K., Beldjord C.,
RA   Vallat J.-M., Merlini L., Voit T., Sewry C., Urtizberea J.A., Romero N.B.,
RA   Tome F.M.S., Fardeau M., Sunada Y., Campbell K.P., Kaplan J.-C.,
RA   Jeanpierre M.;
RT   "Mutational diversity and hot spots in the alpha-sarcoglycan gene in
RT   autosomal recessive muscular dystrophy (LGMD2D).";
RL   J. Med. Genet. 34:470-475(1997).
RN   [12]
RP   VARIANTS LGMDR3 PRO-31; CYS-77; VAL-93; GLY-97; THR-124; PHE-158; PRO-173;
RP   ILE-196; HIS-205 AND GLN-228.
RX   PubMed=9032047; DOI=10.1056/nejm199702273360904;
RA   Duggan D.J., Gorospe J.R., Fanin M., Hoffman E.P., Angelini C.;
RT   "Mutations in the sarcoglycan genes in patients with myopathy.";
RL   N. Engl. J. Med. 336:618-624(1997).
RN   [13]
RP   VARIANT LGMDR3 CYS-284.
RX   PubMed=9585331;
RX   DOI=10.1002/(sici)1097-4598(199806)21:6<769::aid-mus9>3.0.co;2-5;
RA   Angelini C., Fanin M., Menegazzo E., Freda M.P., Duggan D.J., Hoffman E.P.;
RT   "Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic
RT   and one steroid-responsive mild limb-girdle muscular dystrophy patient.";
RL   Muscle Nerve 21:769-775(1998).
RN   [14]
RP   VARIANT LGMDR3 PRO-89.
RX   PubMed=18996010; DOI=10.1016/j.nmd.2008.08.003;
RA   Klinge L., Dekomien G., Aboumousa A., Charlton R., Epplen J.T., Barresi R.,
RA   Bushby K., Straub V.;
RT   "Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?";
RL   Neuromuscul. Disord. 18:934-941(2008).
RN   [15]
RP   VARIANTS LGMDR3 TRP-74; PHE-76 AND CYS-81.
RX   PubMed=30345904; DOI=10.1152/physiolgenomics.00036.2018;
RA   Saha M., Reddy H.M., Salih M., Estrella E., Jones M.D., Mitsuhashi S.,
RA   Cho K.A., Suzuki-Hatano S., Rizzo S.A., Hamad M.H., Mukhtar M.M.,
RA   Hamed A.A., Elseed M.A., Lek M., Valkanas E., MacArthur D.G., Kunkel L.M.,
RA   Pacak C.A., Draper I., Kang P.B.;
RT   "The impact of PYROXD1 deficiency on cellular respiration and correlations
RT   with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and
RT   Sudan.";
RL   Physiol. Genomics 50:929-939(2018).
CC   -!- FUNCTION: Component of the sarcoglycan complex, a subcomplex of the
CC       dystrophin-glycoprotein complex which forms a link between the F-actin
CC       cytoskeleton and the extracellular matrix.
CC   -!- SUBUNIT: Interacts with the syntrophin SNTA1. Cross-link to form 2
CC       major subcomplexes: one consisting of SGCB, SGCD and SGCG and the other
CC       consisting of SGCB and SGCD. The association between SGCB and SGCG is
CC       particularly strong while SGCA is loosely associated with the other
CC       sarcoglycans (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q16586; P54725: RAD23A; NbExp=3; IntAct=EBI-5663553, EBI-746453;
CC       Q16586; P50454: SERPINH1; NbExp=3; IntAct=EBI-5663553, EBI-350723;
CC       Q16586; O43765: SGTA; NbExp=13; IntAct=EBI-5663553, EBI-347996;
CC       Q16586; Q96EQ0: SGTB; NbExp=3; IntAct=EBI-5663553, EBI-744081;
CC       Q16586; P37173: TGFBR2; NbExp=3; IntAct=EBI-5663553, EBI-296151;
CC       Q16586-2; O43765: SGTA; NbExp=4; IntAct=EBI-16434133, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250}; Single-
CC       pass type I membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=SGCA-1;
CC         IsoId=Q16586-1; Sequence=Displayed;
CC       Name=SGCA-2;
CC         IsoId=Q16586-2; Sequence=VSP_006017;
CC   -!- TISSUE SPECIFICITY: Most strongly expressed in skeletal muscle. Also
CC       expressed in cardiac muscle and, at much lower levels, in lung. In the
CC       fetus, most abundant in cardiac muscle and, at lower levels, in lung.
CC       Also detected in liver and kidney. Not expressed in brain.
CC   -!- DISEASE: Muscular dystrophy, limb-girdle, autosomal recessive 3
CC       (LGMDR3) [MIM:608099]: An autosomal recessive degenerative myopathy
CC       characterized by progressive muscle wasting from early childhood with
CC       loss of independent ambulation by teenage years. Muscle biopsy shows
CC       necrosis, decreased immunostaining for alpha sarcoglycan, and adhalin
CC       deficiency. {ECO:0000269|PubMed:18996010, ECO:0000269|PubMed:30345904,
CC       ECO:0000269|PubMed:7657792, ECO:0000269|PubMed:7663524,
CC       ECO:0000269|PubMed:8069911, ECO:0000269|PubMed:8528203,
CC       ECO:0000269|PubMed:9032047, ECO:0000269|PubMed:9192266,
CC       ECO:0000269|PubMed:9585331}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sarcoglycan alpha/epsilon family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Leiden Muscular Dystrophy pages; Note=SGCA mutations
CC       in LGMD2D;
CC       URL="https://www.dmd.nl/sgca_home.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U08895; AAA81637.1; -; mRNA.
DR   EMBL; L34355; AAA35510.1; -; mRNA.
DR   EMBL; L35853; AAA50461.1; -; mRNA.
DR   EMBL; AK290622; BAF83311.1; -; mRNA.
DR   EMBL; AC015909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94635.1; -; Genomic_DNA.
DR   EMBL; BC025702; AAH25702.1; -; mRNA.
DR   EMBL; L46810; AAC37583.1; -; mRNA.
DR   CCDS; CCDS32679.1; -. [Q16586-1]
DR   CCDS; CCDS45729.1; -. [Q16586-2]
DR   PIR; A54746; A54746.
DR   RefSeq; NP_000014.1; NM_000023.4. [Q16586-1]
DR   RefSeq; NP_001129169.1; NM_001135697.3. [Q16586-2]
DR   AlphaFoldDB; Q16586; -.
DR   SMR; Q16586; -.
DR   BioGRID; 112340; 131.
DR   ComplexPortal; CPX-2424; Dystrophin glycoprotein complex, skeletal muscle variant.
DR   ComplexPortal; CPX-2443; Dystrophin glycoprotein complex, neuromuscular junction variant.
DR   ComplexPortal; CPX-2454; Dystrophin glycoprotein complex, retinal outer plexiform layer variant.
DR   ComplexPortal; CPX-2455; Dystrophin glycoprotein complex, retinal inner limiting membrane variant.
DR   CORUM; Q16586; -.
DR   FunCoup; Q16586; 20.
DR   IntAct; Q16586; 103.
DR   MINT; Q16586; -.
DR   STRING; 9606.ENSP00000262018; -.
DR   GlyCosmos; Q16586; 2 sites, No reported glycans.
DR   GlyGen; Q16586; 3 sites.
DR   PhosphoSitePlus; Q16586; -.
DR   SwissPalm; Q16586; -.
DR   BioMuta; SGCA; -.
DR   MassIVE; Q16586; -.
DR   PaxDb; 9606-ENSP00000262018; -.
DR   PeptideAtlas; Q16586; -.
DR   ProteomicsDB; 60931; -. [Q16586-1]
DR   ProteomicsDB; 60932; -. [Q16586-2]
DR   Antibodypedia; 2323; 215 antibodies from 32 providers.
DR   DNASU; 6442; -.
DR   Ensembl; ENST00000262018.8; ENSP00000262018.3; ENSG00000108823.17. [Q16586-1]
DR   Ensembl; ENST00000344627.10; ENSP00000345522.6; ENSG00000108823.17. [Q16586-2]
DR   GeneID; 6442; -.
DR   KEGG; hsa:6442; -.
DR   MANE-Select; ENST00000262018.8; ENSP00000262018.3; NM_000023.4; NP_000014.1.
DR   UCSC; uc002iqi.4; human. [Q16586-1]
DR   AGR; HGNC:10805; -.
DR   CTD; 6442; -.
DR   DisGeNET; 6442; -.
DR   GeneCards; SGCA; -.
DR   HGNC; HGNC:10805; SGCA.
DR   HPA; ENSG00000108823; Group enriched (heart muscle, skeletal muscle, tongue).
DR   MalaCards; SGCA; -.
DR   MIM; 600119; gene.
DR   MIM; 608099; phenotype.
DR   neXtProt; NX_Q16586; -.
DR   OpenTargets; ENSG00000108823; -.
DR   Orphanet; 62; Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3.
DR   PharmGKB; PA35716; -.
DR   VEuPathDB; HostDB:ENSG00000108823; -.
DR   eggNOG; KOG4482; Eukaryota.
DR   GeneTree; ENSGT00390000005672; -.
DR   HOGENOM; CLU_053258_0_0_1; -.
DR   InParanoid; Q16586; -.
DR   OMA; VGSEQYF; -.
DR   OrthoDB; 10019906at2759; -.
DR   PAN-GO; Q16586; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q16586; -.
DR   TreeFam; TF314655; -.
DR   PathwayCommons; Q16586; -.
DR   Reactome; R-HSA-9913351; Formation of the dystrophin-glycoprotein complex (DGC).
DR   SignaLink; Q16586; -.
DR   SIGNOR; Q16586; -.
DR   BioGRID-ORCS; 6442; 23 hits in 1146 CRISPR screens.
DR   ChiTaRS; SGCA; human.
DR   GeneWiki; SGCA; -.
DR   GenomeRNAi; 6442; -.
DR   Pharos; Q16586; Tbio.
DR   PRO; PR:Q16586; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q16586; protein.
DR   Bgee; ENSG00000108823; Expressed in hindlimb stylopod muscle and 120 other cell types or tissues.
DR   ExpressionAtlas; Q16586; baseline and differential.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0016012; C:sarcoglycan complex; IBA:GO_Central.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   InterPro; IPR006644; Cadg.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR008908; Sarcoglycan_alpha/epsilon.
DR   InterPro; IPR048347; Sarcoglycan_C.
DR   InterPro; IPR048346; Sarcoglycan_N.
DR   PANTHER; PTHR10132; ALPHA-/EPSILON-SARCOGLYCAN FAMILY MEMBER; 1.
DR   PANTHER; PTHR10132:SF16; ALPHA-SARCOGLYCAN; 1.
DR   Pfam; PF05510; Sarcoglycan_2; 1.
DR   Pfam; PF20989; Sarcoglycan_2_C; 1.
DR   SMART; SM00736; CADG; 1.
DR   SUPFAM; SSF49313; Cadherin-like; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Disease variant; Glycoprotein; Limb-girdle muscular dystrophy; Membrane;
KW   Phosphoprotein; Proteomics identification; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..387
FT                   /note="Alpha-sarcoglycan"
FT                   /id="PRO_0000031673"
FT   TOPO_DOM        24..290
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        291..311
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        312..387
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P82350"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         196..319
FT                   /note="Missing (in isoform SGCA-2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006017"
FT   VARIANT         30
FT                   /note="P -> L (in LGMDR3; dbSNP:rs886043256)"
FT                   /evidence="ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010402"
FT   VARIANT         31
FT                   /note="L -> P (in LGMDR3; dbSNP:rs903823830)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010403"
FT   VARIANT         34
FT                   /note="R -> C (in LGMDR3; dbSNP:rs758647756)"
FT                   /evidence="ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010404"
FT   VARIANT         34
FT                   /note="R -> H (in LGMDR3; dbSNP:rs371675217)"
FT                   /evidence="ECO:0000269|PubMed:7663524"
FT                   /id="VAR_010405"
FT   VARIANT         62
FT                   /note="Y -> H (in LGMDR3; dbSNP:rs2144494074)"
FT                   /evidence="ECO:0000269|PubMed:7663524"
FT                   /id="VAR_010406"
FT   VARIANT         68
FT                   /note="G -> E (in LGMDR3; dbSNP:rs2144494148)"
FT                   /evidence="ECO:0000269|PubMed:7663524"
FT                   /id="VAR_010407"
FT   VARIANT         74
FT                   /note="R -> W (in LGMDR3; dbSNP:rs757888349)"
FT                   /evidence="ECO:0000269|PubMed:30345904"
FT                   /id="VAR_010408"
FT   VARIANT         76
FT                   /note="L -> F (in LGMDR3; dbSNP:rs1555568335)"
FT                   /evidence="ECO:0000269|PubMed:30345904"
FT                   /id="VAR_081098"
FT   VARIANT         77
FT                   /note="R -> C (in LGMDR3; dbSNP:rs28933693)"
FT                   /evidence="ECO:0000269|PubMed:7657792,
FT                   ECO:0000269|PubMed:7663524, ECO:0000269|PubMed:8528203,
FT                   ECO:0000269|PubMed:9032047, ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010387"
FT   VARIANT         81
FT                   /note="R -> C (in LGMDR3; dbSNP:rs398123098)"
FT                   /evidence="ECO:0000269|PubMed:30345904"
FT                   /id="VAR_081099"
FT   VARIANT         89
FT                   /note="L -> P (in LGMDR3; dbSNP:rs1435014211)"
FT                   /evidence="ECO:0000269|PubMed:18996010"
FT                   /id="VAR_010409"
FT   VARIANT         91
FT                   /note="G -> R (in LGMDR3)"
FT                   /evidence="ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010410"
FT   VARIANT         93
FT                   /note="A -> V (in LGMDR3)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010411"
FT   VARIANT         97
FT                   /note="D -> G (in LGMDR3; dbSNP:rs1555568396)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010412"
FT   VARIANT         98
FT                   /note="R -> C (in LGMDR3; dbSNP:rs138945081)"
FT                   /id="VAR_010413"
FT   VARIANT         98
FT                   /note="R -> H (in LGMDR3; dbSNP:rs137852621)"
FT                   /evidence="ECO:0000269|PubMed:7663524,
FT                   ECO:0000269|PubMed:8069911"
FT                   /id="VAR_010388"
FT   VARIANT         103
FT                   /note="I -> T (in LGMDR3; dbSNP:rs1161291343)"
FT                   /id="VAR_010414"
FT   VARIANT         124
FT                   /note="I -> T (in LGMDR3; dbSNP:rs768814872)"
FT                   /evidence="ECO:0000269|PubMed:9032047,
FT                   ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010415"
FT   VARIANT         136
FT                   /note="A -> APGAQP (in LGMDR3; associated with G-137)"
FT                   /evidence="ECO:0000269|PubMed:7657792"
FT                   /id="VAR_037965"
FT   VARIANT         137
FT                   /note="E -> G (in LGMDR3; associated with P-G-A-Q-P-136
FT                   ins; dbSNP:rs397514451)"
FT                   /evidence="ECO:0000269|PubMed:7657792"
FT                   /id="VAR_037966"
FT   VARIANT         137
FT                   /note="E -> K (in LGMDR3; dbSNP:rs372210292)"
FT                   /evidence="ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010416"
FT   VARIANT         158
FT                   /note="L -> F (in LGMDR3; dbSNP:rs2144496721)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010417"
FT   VARIANT         173
FT                   /note="L -> P (in LGMDR3; dbSNP:rs143962150)"
FT                   /evidence="ECO:0000269|PubMed:9032047,
FT                   ECO:0000269|PubMed:9192266"
FT                   /id="VAR_010431"
FT   VARIANT         175
FT                   /note="V -> A (in LGMDR3; dbSNP:rs137852622)"
FT                   /evidence="ECO:0000269|PubMed:8069911"
FT                   /id="VAR_010389"
FT   VARIANT         196
FT                   /note="V -> I (in LGMDR3; dbSNP:rs752695991)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010418"
FT   VARIANT         205
FT                   /note="P -> H (in LGMDR3; dbSNP:rs757481230)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010419"
FT   VARIANT         228
FT                   /note="P -> Q (in LGMDR3)"
FT                   /evidence="ECO:0000269|PubMed:9032047"
FT                   /id="VAR_010432"
FT   VARIANT         242
FT                   /note="V -> A (in LGMDR3; dbSNP:rs1384158714)"
FT                   /evidence="ECO:0000269|PubMed:7663524"
FT                   /id="VAR_010420"
FT   VARIANT         247
FT                   /note="V -> M (in LGMDR3; dbSNP:rs143570936)"
FT                   /evidence="ECO:0000269|PubMed:7663524"
FT                   /id="VAR_010433"
FT   VARIANT         284
FT                   /note="R -> C (in LGMDR3; dbSNP:rs137852623)"
FT                   /evidence="ECO:0000269|PubMed:9192266,
FT                   ECO:0000269|PubMed:9585331"
FT                   /id="VAR_010390"
SQ   SEQUENCE   387 AA;  42875 MW;  9CD0270A00BE03E6 CRC64;
     MAETLFWTPL LVVLLAGLGD TEAQQTTLHP LVGRVFVHTL DHETFLSLPE HVAVPPAVHI
     TYHAHLQGHP DLPRWLRYTQ RSPHHPGFLY GSATPEDRGL QVIEVTAYNR DSFDTTRQRL
     VLEIGDPEGP LLPYQAEFLV RSHDAEEVLP STPASRFLSA LGGLWEPGEL QLLNVTSALD
     RGGRVPLPIE GRKEGVYIKV GSASPFSTCL KMVASPDSHA RCAQGQPPLL SCYDTLAPHF
     RVDWCNVTLV DKSVPEPADE VPTPGDGILE HDPFFCPPTE APDRDFLVDA LVTLLVPLLV
     ALLLTLLLAY VMCCRREGRL KRDLATSDIQ MVHHCTIHGN TEELRQMAAS REVPRPLSTL
     PMFNVHTGER LPPRVDSAQV PLILDQH
//
